Effect of Alprazolam on Redox Status in Renal Transplantation Donors and Recipients.


Can M., Kocyigit O. I., Aksu U., ÖZER A., Toraman F.

Annals of transplantation, cilt.22, ss.354-360, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22
  • Basım Tarihi: 2017
  • Doi Numarası: 10.12659/aot.903695
  • Dergi Adı: Annals of transplantation
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.354-360
  • Anahtar Kelimeler: Alprazolam, Antioxidants, Kidney Transplantation, Premedication, OXIDATIVE STRESS, SIALIC-ACID, PLASMA, HEMODIALYSIS
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: Benzodiazepines are the most popular premedication drugs thought to act through the GABA/benzodiazepine receptor complex and alprazolam is one of the most potent benzodiazepines that have a quick onset. While there is a growing body of evidence supporting alprazolam in the amelioration of redox status in animals, no study has been performed concerning its antioxidant activity in humans. The purpose of this investigation was to determine the effect of alprazolam on redox status.